Igene Biotechnology, Inc. (IGNE)

USD 0.0

(0.0%)

Total Liabilities Summary of Igene Biotechnology, Inc.

Igene Biotechnology, Inc.'s latest annual total liabilities in 2009 was 7.5 Million USD , down -14.2% from previous year.
Igene Biotechnology, Inc.'s latest quarterly total liabilities in 2010 Q3 was 8.09 Million USD , up 0.48% from previous quarter.
Igene Biotechnology, Inc. reported annual total liabilities of 8.74 Million USD in 2008, down -68.16% from previous year.
Igene Biotechnology, Inc. reported annual total liabilities of 27.45 Million USD in 2007, up 66.48% from previous year.
Igene Biotechnology, Inc. reported quarterly total liabilities of 8.06 Million USD for 2010 Q2, up 2.15% from previous quarter.
Igene Biotechnology, Inc. reported quarterly total liabilities of 8.09 Million USD for 2010 Q3, up 0.48% from previous quarter.

Annual Total Liabilities Chart of Igene Biotechnology, Inc. (2009 - 1999)

Historical Annual Total Liabilities of Igene Biotechnology, Inc. (2009 - 1999)

Year	Total Liabilities	Total Liabilities Growth
2009	7.5 Million USD	-14.2%
2008	8.74 Million USD	-68.16%
2007	27.45 Million USD	66.48%
2006	16.49 Million USD	0.0%
2003	16.34 Million USD	-3.91%
2002	17.01 Million USD	17.15%
2001	14.52 Million USD	47.9%
2000	9.81 Million USD	12.83%
1999	8.7 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2010 Q1	7.89 Million USD	5.18%
2010 Q2	8.06 Million USD	2.15%
2010 Q3	8.09 Million USD	0.48%
2009 Q4	7.5 Million USD	-6.75%
2009 Q3	8.04 Million USD	5.61%
2009 FY	7.5 Million USD	-14.2%
2009 Q1	7.3 Million USD	-16.42%
2009 Q2	7.61 Million USD	4.25%
2008 Q2	24.95 Million USD	-7.0%
2008 FY	8.74 Million USD	-68.16%
2008 Q4	8.74 Million USD	-64.36%
2008 Q3	24.53 Million USD	-1.68%
2008 Q1	26.83 Million USD	-2.28%
2007 Q3	14.13 Million USD	3.92%
2007 FY	27.45 Million USD	66.48%
2007 Q4	27.45 Million USD	94.29%
2007 Q2	13.6 Million USD	-18.03%
2007 Q1	16.59 Million USD	0.6%
2006 FY	16.49 Million USD	0.0%
2006 Q3	16.21 Million USD	0.0%
2006 Q4	16.49 Million USD	1.72%
2004 Q3	14.97 Million USD	1.12%
2004 Q1	16.6 Million USD	1.58%
2004 Q2	14.81 Million USD	-10.78%
2003 Q3	16.12 Million USD	-2.28%
2003 FY	16.34 Million USD	-3.91%
2003 Q4	16.34 Million USD	1.37%
2003 Q2	16.5 Million USD	0.58%
2003 Q1	16.4 Million USD	-3.56%
2002 Q4	17.01 Million USD	1.49%
2002 Q3	16.76 Million USD	-0.44%
2002 Q1	15.32 Million USD	5.56%
2002 FY	17.01 Million USD	17.15%
2002 Q2	16.83 Million USD	9.83%
2001 FY	14.52 Million USD	47.9%
2001 Q3	13.11 Million USD	7.45%
2001 Q2	12.2 Million USD	6.86%
2001 Q4	14.52 Million USD	10.71%
2001 Q1	11.42 Million USD	16.35%
2000 Q3	9.42 Million USD	5.18%
2000 Q1	8.8 Million USD	0.0%
2000 FY	9.81 Million USD	12.83%
2000 Q4	9.81 Million USD	4.21%
2000 Q2	8.95 Million USD	1.68%
1999 FY	8.7 Million USD	0.0%

Peer Total Liabilities Comparison of Igene Biotechnology, Inc.

Name	Total Liabilities	Total Liabilities Difference
Allied Energy Corporation	4.34 Million USD	-72.577%
Earth Alive Clean Technologies Inc.	994.33 Thousand USD	-654.507%
Lotus Bio-Technology Development Corp.	- USD	-Infinity%
MagIndustries Corp.	99.83 Million USD	92.485%
Itafos Inc.	346.68 Million USD	97.836%
Potash America, Inc.	2.33 Million USD	-221.77%
Yara International ASA	8.45 Billion USD	99.911%
Yara International ASA	8.43 Billion USD	99.911%